A new study reveals that a common genetic variant linked to Alzheimer’s disease may also influence the risk of developing severe COVID-19 outcomes. Researchers found that individuals carrying the APOE4 gene variant—already known for its association with Alzheimer’s—experienced higher rates of hospitalization and worse respiratory complications when infected with the coronavirus. The findings suggest a potential biological connection between neurodegenerative conditions and COVID-19 severity, though further investigation is needed to clarify the exact mechanisms. Experts caution that the discovery could have implications for understanding long-term health risks in vulnerable populations.
